Panel 3: A Value-Based Approach to Drug Pricing (Unpacking Drug Value) | Kaiser Permanente
Channel: Kaiser Permanente
Date: 24/09/2019

Polly Webster, JD, MPH
Senior Policy Advisor, Government Relations
Kaiser Permanente

Hemi D. Tewarson, JD, MPH
Director, NGA Health
National Governors Association

Leigh Purvis, MPA
Director, Health Services Research
AARP Public Policy Institute

Bari Talente, JD
Executive Vice President, Advocacy
National Multiple Sclerosis Society

Sean Dickson, JD, MPH
Director, Health Policy
West Health Policy Center